Rev 10/11/2026 · Master Clinical Training Suite

DLP 23: Robert Langdon

Complete Clinical Lifecycle: Patient Portal Registration, Annual Procedure Consent Renewal Screening (MED-ANTICOAG-NSAID), Arrival Clock Reset, Check-In Safety Clearance, Visible Rooming, Clinical Intake Vitals, Botox Cosmetic Anatomical Neurotoxin Therapy, and Square Terminal POS Checkout.

Scenario 23 MED-ANTICOAG-NSAID Dr. Ravi Sundaram, MD Square Terminal POS ($800.00) 100% Pass Validated
DLP 01: Kailani DLP 14: Marcus Vance DLP 15: Devon Chen DLP 16: Amara Okafor DLP 17: Sophia Valenti DLP 18: Liam Gallagher DLP 23: Robert Langdon
Interactive Scene Jump Points
Click any chapter to seek directly to that clinical milestone

Clinical Safety Governance

Scenario Code: DLP-SCR-23

Governing Rule: MED-ANTICOAG-NSAID (Patient taking Eliquis / Plavix / high-dose NSAID)

Clinical Protocol: When an intake registration discloses current antiplatelet, anticoagulant, or high-dose NSAID therapy, the clinical safety engine quarantines the card at Intake Incomplete until front-desk staff verifies withholding protocols and clinician bruising clearance on camera.

Patient & Provider Demographics

Patient Persona: Robert Langdon (Male, DOB: 1990-05-15, Age 36)

Address: 6400 N Western Ave, Oklahoma City, OK 73116

Phone: (405) 555-0123 | SSN Last 4: 4023

Attending Clinician: Dr. Ravi Sundaram, MD

Clinical Coordinator: Sarah Jenkins | Clinical Assistant: Alex Morgan, PA-C

Documented Treatment & Settlement

Primary Treatment: Restylane L 1.0mL with Micro-Cannula Technique (1 syringe, $800.00)

Adjunctive Service: Comprehensive Aesthetic Consultation & Evaluation ($0.00)

Tender Method: Square Terminal POS Device (In-Person)

Transaction Settlement: Approved #TX-73118-POS | Balance Due: $0.00

Audit Invariant: Patient card retained in Lane 12 (Completed) for statutory census reconciliation.